CLL/SLL in 2020

Learning Objectives

 

  • Understand treatment parameters for CLL/SLL
  • Understand similarities/differences between MBL/CLL/SLL
  • Understand high risk vs low risk CLL/SLL and associated best treatments based on these findings
  • Emphasize the importance of testing for IGHV status and clinical implications
  • Understand common treatment options with focus on shifting away from CIT for many patients given success of novel therapies (oral agents and immunotherapies)

 

Course summary

Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
Registration Opens: 
01/16/2020
Registration Expires: 
01/15/2022
Part of: 
Advanced Practice Provider Webinar Lecture Series 2020
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
Please login or register to take this course.